Navigation Links
Neurocrine Biosciences Announces Conference Call and Webcast To Present Second Quarter 2008 Financial Results
Date:7/23/2008

Conference Call and Webcast Scheduled for Wednesday, July 30

SAN DIEGO, July 23 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report its second quarter 2008 financial results after the Nasdaq market closes on Wednesday, July 30, 2008. Neurocrine will host a live conference call and webcast to discuss its financial results and provide a Company update Wednesday afternoon, July 30, 2008 at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).

Participants can access the live conference call by dialing 1-800-862-9098 (US) or 785-424-1051 (International) using the conference ID: 7NBIX2. The call can also be accessed via the webcast through the Company's website at http://www.neurocrine.com

If you are unable to attend the Webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600. A replay of the Conference Call will be available approximately one hour after the conclusion of the call by dialing 1-800-283-4641 (US) or 402-220-0851 (International) using the conference ID: 7NBIX2. The call will be archived for two weeks.

Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. The product candidates address some of the largest pharmaceutical markets in the world including endometriosis, irritable bowel syndrome, anxiety, depression, pain, diabetes, insomnia, and other neurological and endocrine related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Neurocrine Biosciences to Present at the 2008 Citi Investment Research Global Health Care Conference
2. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2008 Financial Results
3. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2007 Financial Results
4. Neurocrine Announces Appointment of Kevin Gorman, Ph.D., as President and Chief Executive Officer
5. Neurocrine Announces Work Force Restructuring
6. Neurocrine Receives Approvable Letter for Indiplon Capsules with Additional Safety and Efficacy Data Required by FDA
7. Neurocrine Biosciences Announces Conference Call and Webcast to Provide Indiplon Update
8. Neurocrine Biosciences and Dainippon Sumitomo Pharma (DSP) Announce Agreement to Develop and Commercialize Indiplon in Japan
9. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2007 Financial Results
10. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
11. Neurocrine Biosciences to Present at the A.G. Edwards Annual Emerging Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... South Jordan, UT, and Portland, OR (PRWEB) , ... ... ... CallTower , an industry-leading Unified Communications (UC) and Collaboration ... cloud performance in real-time, announced today a strategic alliance to extend CallTower’s ...
(Date:9/22/2017)... ... 22, 2017 , ... HOLLOWAY AMERICA, a stainless steel pressure ... event PACK EXPO International in Las Vegas from September 25 to 27. The ... this year’s PACK EXPO at the Last Vegas Convention Center, HOLLOWAY representatives will ...
(Date:9/21/2017)... ... September 21, 2017 , ... Vixiar ... executive, engineering and manufacturing functions to The LaunchPort™ Accelerator at the City Garage ... full range of manufacturing and business services to its Residents. , Vixiar ...
(Date:9/21/2017)... Philadelphia PA and London UK (PRWEB) , ... ... ... from DrugDev , a QuintilesIMS company, who enable the world’s most progressive ... learned from over 2,000 clinical trials at top pharma and biotech events in ...
Breaking Biology Technology:
(Date:4/11/2017)... , April 11, 2017 Crossmatch®, a ... authentication solutions, today announced that it has been ... Research Projects Activity (IARPA) to develop next-generation Presentation ... "Innovation has been a driving force ... program will allow us to innovate and develop ...
(Date:4/11/2017)... 11, 2017 NXT-ID, Inc. (NASDAQ:   ... announces the appointment of independent Directors Mr. Robin D. ... Board of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , ... forward to their guidance and benefiting from their considerable expertise ...
(Date:4/5/2017)... 2017 Today HYPR Corp. , leading ... component of the HYPR platform is officially FIDO® ... security architecture that empowers biometric authentication across Fortune 500 ... secured over 15 million users across the financial services ... home product suites and physical access represent a growing ...
Breaking Biology News(10 mins):